Home >> Research Area >>Others>>FLAP>> GSK2190915 sodium salt

GSK2190915 sodium salt

CAS# 1196070-26-4

GSK2190915 sodium salt

Catalog No. BCC5588----Order now to get a substantial discount!

Product Name & Size Price Stock
GSK2190915 sodium salt: 5mg $138 In Stock
GSK2190915 sodium salt: 10mg Please Inquire In Stock
GSK2190915 sodium salt: 20mg Please Inquire Please Inquire
GSK2190915 sodium salt: 50mg Please Inquire Please Inquire
GSK2190915 sodium salt: 100mg Please Inquire Please Inquire
GSK2190915 sodium salt: 200mg Please Inquire Please Inquire
GSK2190915 sodium salt: 500mg Please Inquire Please Inquire
GSK2190915 sodium salt: 1000mg Please Inquire Please Inquire
Related Products
  • PP242

    Catalog No.:BCC3682
    CAS No.:1092351-67-1
  • A66

    Catalog No.:BCC3715
    CAS No.:1166227-08-2
  • CAL-101 (Idelalisib, GS-1101)

    Catalog No.:BCC1270
    CAS No.:870281-82-6
  • PIK-294

    Catalog No.:BCC4995
    CAS No.:900185-02-6
  • OSI-027

    Catalog No.:BCC4603
    CAS No.:936890-98-1
  • KU-0063794

    Catalog No.:BCC2484
    CAS No.:938440-64-3

Quality Control of GSK2190915 sodium salt

Number of papers citing our products

Chemical structure

GSK2190915 sodium salt

3D structure

Chemical Properties of GSK2190915 sodium salt

Cas No. 1196070-26-4 SDF Download SDF
PubChem ID 44473150 Appearance Powder
Formula C38H42N3NaO4S M.Wt 659.81
Type of Compound N/A Storage Desiccate at -20°C
Synonyms GSK-2190915A; Fiboflapon sodium; AM-803 sodium
Solubility DMSO : ≥ 32 mg/mL (48.50 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate
SMILES CCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)[O-])SC(C)(C)C.[Na+]
Standard InChIKey NOJNFULGOQGBKB-UHFFFAOYSA-M
Standard InChI InChI=1S/C38H43N3O4S.Na/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43;/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43);/q;+1/p-1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

GSK2190915 sodium salt Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

GSK2190915 sodium salt Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of GSK2190915 sodium salt

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.5156 mL 7.5779 mL 15.1559 mL 30.3118 mL 37.8897 mL
5 mM 0.3031 mL 1.5156 mL 3.0312 mL 6.0624 mL 7.5779 mL
10 mM 0.1516 mL 0.7578 mL 1.5156 mL 3.0312 mL 3.789 mL
50 mM 0.0303 mL 0.1516 mL 0.3031 mL 0.6062 mL 0.7578 mL
100 mM 0.0152 mL 0.0758 mL 0.1516 mL 0.3031 mL 0.3789 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on GSK2190915 sodium salt

GSK2190915(AM-803; Fiboflapon) sodium salt is a potent FLAP(5-Lipoxygenase-activating protein) inhibitor with binding IC50 of 2.9 nM. IC50 value: 76 nM (inhibition of LTB4 in human blood 5 h incubation) [1] Target: FLAP inhibitor GSK2190915 exhibits excellent preclinical toxicology and pharmacokinetics in rat and dog. GSK2190915 also demonstrated an extended pharmacodynamic effect in a rodent bronchoalveolar lavage (BAL) model [1]. Oral administration of AM803 (1 mg/kg) resulted in sustained inhibition of ex vivo ionophore-challenged whole blood LTB4 biosynthesis with >90% inhibition for up to 12 h and an EC50 of approximately 7 nM. When rat lungs were challenged in vivo with calcium-ionophore, AM803 inhibited LTB4 and cysteinyl leukotriene (CysLT) production with ED50s of 0.12 mg/kg and 0.37 mg/kg, respectively. The inhibition measured 16 h following a single oral dose of 3 mg/kg was 86% and 41% for LTB4 and CysLTs, respectively. In an acute inflammation setting, AM803 dose-dependently reduced LTB4, CysLTs, plasma protein extravasation and neutrophil influx induced by peritoneal zymosan injection. Finally, AM803 increased survival time in mice exposed to a lethal intravenous injection of platelet activating factor (PAF) [2].

References:
[1]. Stock NS, et al. 5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once [2]. Lorrain DS, et al. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. Eur J Pharmacol. 2010 Aug 25;640(1-3):211-8.

Featured Products
New Products
 

Description

Fiboflapon sodium (GSK2190915; AM-803) is a potent and orally bioavailable 5-lipoxygenase-activating protein (FLAP) inhibitor with a potency of 2.9 nM in FLAP binding, an IC50 of 76 nM for inhibition of LTB4 in human blood.

Keywords:

GSK2190915 sodium salt,1196070-26-4,GSK-2190915A; Fiboflapon sodium; AM-803 sodium,Natural Products,FLAP, buy GSK2190915 sodium salt , GSK2190915 sodium salt supplier , purchase GSK2190915 sodium salt , GSK2190915 sodium salt cost , GSK2190915 sodium salt manufacturer , order GSK2190915 sodium salt , high purity GSK2190915 sodium salt

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: